Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain) - PubMed (original) (raw)
Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain)
Irene Vinagre et al. Diabetes Care. 2012 Apr.
Abstract
Objective: The objective of this study was to analyze the clinical characteristics and levels of glycemic and cardiovascular risk factor control in patients with type 2 diabetes that are in primary health care centers in Catalonia (Spain).
Research design and methods: This was a cross-sectional study of a total population of 3,755,038 individuals aged 31-90 years at the end of 2009. Clinical data were obtained retrospectively from electronic clinical records.
Results: A total of 286,791 patients with type 2 diabetes were identified (7.6%). Fifty-four percent were men, mean (SD) age was 68.2 (11.4) years, and mean duration of disease was 6.5 (5.1) years. The mean (SD) A1C value was 7.15 (1.5)%, and 56% of the patients had A1C values ≤7%. The mean (SD) blood pressure (BP) values were 137.2 (13.8)/76.4 (8.3) mmHg, mean total cholesterol concentration was 192 (38.6) mg/dL, mean HDL cholesterol concentration was 49.3 (13.2) mg/dL, mean LDL cholesterol (LDL-C) concentration was 112.5 (32.4) mg/dL, and mean BMI was 29.6 (5) kg/m(2). Thirty-one percent of the patients had BP values ≤130/80 mmHg, 37.9% had LDL-C values ≤100 mg/dL, and 45.4% had BMI values ≤30 kg/m(2). Twenty-two percent were managed exclusively with lifestyle changes. Regarding medicated diabetic patients, 46.9, 22.9, and 2.8% were prescribed one, two, or three antidiabetic drugs, respectively, and 23.4% received insulin therapy.
Conclusions: The results from this study indicate a similar or improved control of glycemia, lipids, and BP in patients with type 2 diabetes when compared with previous studies performed in Spain and elsewhere.
Similar articles
- Achievement of cardiovascular risk factor targets according to sex and previous history of cardiovascular disease in type 2 diabetes: A population-based study.
Galbete A, Cambra K, Forga L, Baquedano FJ, Aizpuru F, Lecea O, Librero J, Ibáñez B. Galbete A, et al. J Diabetes Complications. 2019 Dec;33(12):107445. doi: 10.1016/j.jdiacomp.2019.107445. Epub 2019 Sep 12. J Diabetes Complications. 2019. PMID: 31668588 - Metabolic control and chronic complications during a 3-year follow-up period in a cohort of type 2 diabetic patients attended in primary care in the Community of Madrid (Spain).
Arrieta F, Piñera M, Iglesias P, Nogales P, Salinero-Fort MA, Abanades JC, Botella-Carretero JI, Calañas A, Balsa JA, Zamarrón I, Rovira A, Vázquez C; ESD2 Group. Arrieta F, et al. Endocrinol Nutr. 2014 Jan;61(1):11-7. doi: 10.1016/j.endonu.2013.09.002. Epub 2013 Oct 30. Endocrinol Nutr. 2014. PMID: 24182687 - Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
Corcillo A, Pivin E, Lalubin F, Pitteloud N, Burnier M, Zanchi A. Corcillo A, et al. Swiss Med Wkly. 2017 Jul 6;147:w14459. doi: 10.4414/smw.2017.14459. eCollection 2017. Swiss Med Wkly. 2017. PMID: 28695552 - Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study.
Bertoni AG, Clark JM, Feeney P, Yanovski SZ, Bantle J, Montgomery B, Safford MM, Herman WH, Haffner S; Look AHEAD Research Group. Bertoni AG, et al. J Diabetes Complications. 2008 Jan-Feb;22(1):1-9. doi: 10.1016/j.jdiacomp.2006.10.003. J Diabetes Complications. 2008. PMID: 18191071 Clinical Trial. - Analysis of a sample of type 2 diabetic patients with obesity or overweight and at cardiovascular risk: a cross sectional study in Spain.
Lucha-López MO, Lucha-López AC, Vidal-Peracho C, Tricás-Moreno JM, Estébanez-De Miguel E, Salavera-Bordás C, Hidalgo-García C. Lucha-López MO, et al. BMC Res Notes. 2014 Jan 21;7:48. doi: 10.1186/1756-0500-7-48. BMC Res Notes. 2014. PMID: 24443817 Free PMC article.
Cited by
- Performance of Primary Care Physicians in the Management of Glycemia, Lipids, and Blood Pressure among People with Type 2 Diabetes: A Cross-Sectional Study.
Vlacho B, Fernandez-Camins B, Canudas-Ventura A, Rodríguez A, Mollo À, Cos Claramunt FX, Antentas M, Mauricio D, Franch-Nadal J. Vlacho B, et al. J Clin Med. 2024 Mar 7;13(6):1544. doi: 10.3390/jcm13061544. J Clin Med. 2024. PMID: 38541770 Free PMC article. - Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN).
Tejera-Pérez C, Chico A, Azriel-Mira S, Lardiés-Sánchez B, Gomez-Peralta F; Área de Diabetes-SEEN. Tejera-Pérez C, et al. Diabetes Ther. 2023 Jul;14(7):1077-1091. doi: 10.1007/s13300-023-01417-1. Epub 2023 May 15. Diabetes Ther. 2023. PMID: 37188930 Free PMC article. - Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia.
Genua I, Franch-Nadal J, Navas E, Mata-Cases M, Giménez-Pérez G, Vlacho B, Mauricio D, Goday A. Genua I, et al. Front Endocrinol (Lausanne). 2022 Dec 2;13:1015614. doi: 10.3389/fendo.2022.1015614. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36531459 Free PMC article. Review. - [Cardiovascular preventive recommendations. PAPPS 2022 thematic updates. Working groups of the PAPPS].
Orozco-Beltrán D, Brotons Cuixart C, Banegas Banegas JR, Gil Guillén VF, Cebrián Cuenca AM, Martín Rioboó E, Jordá Baldó A, Vicuña J, Navarro Pérez J. Orozco-Beltrán D, et al. Aten Primaria. 2022 Oct;54 Suppl 1(Suppl 1):102444. doi: 10.1016/j.aprim.2022.102444. Aten Primaria. 2022. PMID: 36435583 Free PMC article. Spanish. - Sex Differences in Cardiovascular Prevention in Type 2: Diabetes in a Real-World Practice Database.
Ramírez-Morros A, Franch-Nadal J, Real J, Gratacòs M, Mauricio D. Ramírez-Morros A, et al. J Clin Med. 2022 Apr 14;11(8):2196. doi: 10.3390/jcm11082196. J Clin Med. 2022. PMID: 35456292 Free PMC article.
References
- Mata M, Antoñanzas J, Tafalla M, Sanz P. The cost of type 2 diabetes in Spain: the CODE-2 study. Gac Sanit 2002;16:511–520 [in Spanish] - PubMed
- American Diabetes Association Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care 2002;25:S28–S32 - PubMed
- Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577–1589 - PubMed
- Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580–591 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical